Back to Search
Start Over
Dômes Pharma y EquiCord se alían para comercializar un medicamento de células madre para el tratamiento de la artrosis canina.
- Source :
- Argos (1699-7875); Jul2022, Issue 240, p27-27, 1/9p
- Publication Year :
- 2022
-
Abstract
- The article reports that French group Dômes has announced the signing of an exclusive association with the Spanish company of EquiCord biotechnology to distribute the first cell-based drug expected mother for the treatment of canine osteoarthritis.
- Subjects :
- DRUGS
OSTEOARTHRITIS in dogs
Subjects
Details
- Language :
- Spanish
- ISSN :
- 16997875
- Issue :
- 240
- Database :
- Complementary Index
- Journal :
- Argos (1699-7875)
- Publication Type :
- Periodical
- Accession number :
- 157574714